These discoveries imply that Meis1 holds promise as a therapeutic target for a range of conditions, including modifying cancer metabolism, targeting cancer stem cells, expanding HSC populations, and promoting cardiac regeneration and possibly preventing cardiotoxicity (Aksoz et al., 2018; Meriç and Kocabas, 2022; Girgin and Kocabas, 2023). Here, MEIS1 is linked to cancer.